Dexcom

Dexcom is a global leader in continuous glucose monitoring (CGM) technology, specializing in the design, development, and commercialization of systems for people with diabetes. Their flagship products, including the Dexcom G6 and G7, provide real-time glucose readings to mobile devices, eliminating the need for routine fingersticks and enabling automated insulin delivery (AID) through integrations with pumps like Omnipod and Tandem. In recent years, Dexcom has expanded beyond the intensive insulin-delivery market into the Type 2 non-insulin and health-and-wellness sectors. This expansion is led by the launch of 'Stelo,' the first over-the-counter glucose biosensor cleared by the FDA, and the development of multi-analyte sensors (G8) capable of tracking additional metabolic biomarkers.